Fecal bacteriotherapy for ulcerative colitis: patients are ready, are we?
about
Prospects and challenges for intestinal microbiome therapy in pediatric gastrointestinal disordersSystematic review: faecal microbiota transplantation therapy for digestive and nondigestive disorders in adults and childrenGut microbial flora, prebiotics, and probiotics in IBD: their current usage and utilityIntestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel diseasePotential use of probiotic and commensal bacteria as non-antibiotic strategies against vancomycin-resistant enterococciMicrobial fingerprinting detects intestinal microbiota dysbiosis in Zebrafish models with chemically-induced enterocolitis.How Chinese clinicians face ethical and social challenges in fecal microbiota transplantation: a questionnaire study.Physician attitudes toward the use of fecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection.Fecal microbiota transplantation in metabolic syndrome: History, present and future.Patient perceptions of fecal microbiota transplantation for ulcerative colitis.Gut Health in the era of the human gut microbiota: from metaphor to biovalue.Why is initial bacterial colonization of the intestine important to infants' and children's health?Fecal microbiota transplantation in inflammatory bowel disease: beyond the excitementMedia Discourse on the Social Acceptability of Fecal Transplants.Fecal Microbiota Transplantation Improves the Quality of Life in Patients with Inflammatory Bowel Disease.Fecal microbiota transplantation in gastrointestinal disease: 2015 update and the road ahead.Clostridium difficile drug pipeline: challenges in discovery and development of new agentsEconomic evaluation of fecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection in Australia.Induced and natural regulatory T cells in the development of inflammatory bowel disease.Patient Perspectives on Fecal Microbiota Transplantation for Clostridium Difficile Infection.Perceptions of fecal microbiota transplantation for Clostridium difficile infection: factors that predict acceptance.Systematic review: faecal microbiota transplantation in the management of inflammatory bowel disease.The microbiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation?New therapeutic avenues in ulcerative colitis: thinking out of the box.The potential role of fecal microbiota transplantation in the treatment of inflammatory Bowel disease.Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease.Ethical Issues in Fecal Microbiota Transplantation in Practice.Curbing our enthusiasm for fecal transplantation in ulcerative colitis.When Subjects Violate the Research Covenant: Lessons Learned from a Failed Clinical Trial of Fecal Microbiota Transplantation.[Microbiota and representations of the human body].Physicians Must Discuss Potential Long-Term Risks of Fecal Microbiota Transplantation to Ensure Informed Consent.Faecal microbiota transplantation and bacteriotherapy for recurrent Clostridium difficile infection: a retrospective evaluation of 31 patients.Applying fecal microbiota transplantation (FMT) to treat recurrent Clostridium difficile infections (rCDI) in children.
P2860
Q24599041-5841C699-366F-4F47-A38E-38BC1E7BDF99Q26859859-5842936F-CD56-4AB0-9DE8-D9E7F70B29F4Q26995672-3A95B4D2-426F-494B-A523-5721F29FAF72Q27003192-787BACA3-BB9C-4619-828C-5667DAA87AD1Q28085151-30C71A7B-2D5B-42E4-BE35-3B55C38204B6Q33643059-40455982-25B5-4543-A7FD-D0FC63F5268FQ33749944-EC1DAAFC-01AE-4C76-B7DA-C0B7FA816537Q33810999-753B7DDB-7338-4ED9-993C-9F6CCB0AF953Q33821397-4F2A7FFE-9CBE-426B-AC16-767902B9FA3EQ34691746-981D2526-961E-4A37-A0D3-7EC254D43034Q35115051-7DBF0011-F478-4DA9-A384-179F7562A4F0Q35122316-C9C15247-0E05-4F3A-9FA5-12761FDFAB15Q35361200-F6DF10D0-6434-4F34-801A-20677447090AQ35543938-2283B842-8586-477A-9860-BF23150DB60CQ35753252-635DAF3D-30F0-4398-B8D2-E29E0C22414AQ35790385-8E6477E5-9831-49DA-8F3A-57257CF5AB9BQ35846436-66E56517-F74B-4FDC-BF13-F89A10F02E16Q35979116-4FFA53C6-6A59-47D1-B597-E19A9983AE5BQ36948341-2ABD0D13-C328-4EAC-91AA-022D81A8BB7EQ37056524-5876792A-92F2-48DF-A195-0CF3911F4E64Q37542865-944B1A07-0FEC-4EB2-B97B-A47B84C4A656Q38029111-D1EE40DA-F5E5-4D89-A784-A652E5593222Q38049252-40346FA5-84E1-4BDC-B262-727B686F7D90Q38150670-AC5F2C0C-CC8C-4F20-930C-139DC46DF9F0Q38661453-3892CF99-C25B-4AB8-869E-EB5C1FAE28C3Q38727911-6FA9C554-5618-47D3-AFDE-560BF908D3FFQ40242658-8AD399B6-F02F-4DDC-911A-ED6B0F1AA04CQ46315019-AC604131-FFD2-4A56-AA34-155EDA43FFC2Q47628108-A23F24EA-CBCE-4E7A-8A0B-9F2DC855E0B3Q50993608-DDD392F8-CC06-4BD2-AC16-3B71BD2FBCE2Q53342550-A441DA4E-6BF6-4336-941B-F0B6774B08B5Q54417278-B3D219BB-192B-4250-AE19-11B1FED51AE8Q55004309-A6E95F4D-DFDE-4398-BD39-7C3C4E79C477
P2860
Fecal bacteriotherapy for ulcerative colitis: patients are ready, are we?
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Fecal bacteriotherapy for ulcerative colitis: patients are ready, are we?
@ast
Fecal bacteriotherapy for ulcerative colitis: patients are ready, are we?
@en
Fecal bacteriotherapy for ulcerative colitis: patients are ready, are we?
@nl
type
label
Fecal bacteriotherapy for ulcerative colitis: patients are ready, are we?
@ast
Fecal bacteriotherapy for ulcerative colitis: patients are ready, are we?
@en
Fecal bacteriotherapy for ulcerative colitis: patients are ready, are we?
@nl
prefLabel
Fecal bacteriotherapy for ulcerative colitis: patients are ready, are we?
@ast
Fecal bacteriotherapy for ulcerative colitis: patients are ready, are we?
@en
Fecal bacteriotherapy for ulcerative colitis: patients are ready, are we?
@nl
P2093
P2860
P356
P1476
Fecal bacteriotherapy for ulcerative colitis: patients are ready, are we?
@en
P2093
David T Rubin
Rita Gorawara-Bhat
Stacy A Kahn
P2860
P304
P356
10.1002/IBD.21775
P577
2011-05-25T00:00:00Z